FOR IMMEDIATE RELEASE
Missouri Home Care
Announces New Treatment Program
Missouri Home Care
Announces New Neuropathy Treatment Program for the Previously Irreversible
Symptoms of Diabetic Peripheral Neuropathy
August 12, 2005
--
Missouri Home Care today announced the
launch of an important new therapy program – the first to demonstrate
restoration of sensation in the feet of diabetic patients with peripheral
neuropathy along with improved gait and balance. The Anodyne®
Neuropathy Care Program is the first to offer hope to patients
for what was thought to be a progressive and irreversible disease.
Diabetic Peripheral Neuropathy
(DPN) is nerve damage associated with diabetes, the symptoms of which
include numbness and/or pain in the feet, legs and hands. Complications
of this devastating condition are reported to cost the U.S. healthcare
system in excess of 37 billion dollars annually and include wounds that
don’t heal for months or years, lower extremity amputations, reduced
mobility and increased risk of falls.
While drugs are sometimes
effective for the pain associated with DPN, no drug or medical device
had previously been shown to increase sensation once it has been
diminished or lost due to DPN. This program follows the clinically
proven protocol published in the Journal of the Podiatric Medical
Association in which clinically significant improvements in
sensation could be measured in 100% of the 1,047 study participants
after only twelve 30-minute treatments (P < .0001).
Regional Vice President, Mary
Kaye Kramme, says: Anodyne Therapy is a painless, non-invasive
treatment performed in the privacy and comfort of the patient’s home.
The successful results of Anodyne Therapy for patients we’ve treated for
DPN have been and dramatic. It’s incredible to see positive outcomes
after only a few Anodyne treatments. We are thrilled to be able to
offer this treatment to our patients.
Our Neuropathy Care Program uses the Anodyneâ
Therapy System as an integral part of each therapy session along with a
personalized physical therapy program. The Anodyne Therapy System is a
patented, FDA-cleared, non-invasive device that uses near-infrared light
emitting diodes to safely increase local circulation and reduce pain.
Use in thousands of patients and over millions of clinical treatments
per year has demonstrated that the Anodyne Therapy System increases
microcirculation in patients with DPN, who often have severe vascular
impairment. The results of this improved circulation have been
published in several medical journals and include improved sensation and
nerve conduction, pain reduction and healing of chronic diabetic
ulcers. New data shows that treatment with this therapy can also
improve balance and gait and reduce the risk of falls by 96% in the
elderly patient with neuropathy. This is the first therapy program to
help patients with all of the devastating complications of DPN.
For more information about Anodyne
click here.
For More Information Contact:
Mary Kaye Kramme, Regional Vice President
Missouri Home Care
1026 Kingshighway
Rolla, MO 65402
Office: 573-364-3610
info@mohomecare.com
|
